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Background: Data routinely collected in electronic health records (EHRs) offer a unique opportunity to monitor chronic health
conditions in real-time. Geographic information systems (GIS) may be an important complement in the analysis of those data.
Objective: The aim of this study was to explore the feasibility of using primary care EHRs and GIS for population care
management and public health surveillance of chronic conditions, in Portugal. Specifically, type 2 diabetes was chosen as a case
study, and we aimed to map its prevalence and the presence of comorbidities, as well as to identify possible populations at risk
for cardiovascular complications.
Methods: Cross-sectional study using individual-level data from 514 primary care centers, collected from three different types
of EHRs. Data were obtained on adult patients with type 2 diabetes (identified by the International Classification of Primary Care
[ICPC-2] code, T90, in the problems list). GISs were used for mapping the prevalence of diabetes and comorbidities (hypertension,
dyslipidemia, and obesity) by parish, in the region of Lisbon and Tagus Valley. Descriptive statistics and multivariate logistic
regression were used for data analysis.
Results: We identified 205,068 individuals with the diagnosis of type 2 diabetes, corresponding to a prevalence of 5.6%
(205,068/3,659,868) in the study population. The mean age of these patients was 67.5 years, and hypertension was present in
71% (144,938/205,068) of all individuals. There was considerable variation in diagnosed comorbidities across parishes. Diabetes
patients with concomitant hypertension or dyslipidemia showed higher odds of having been diagnosed with cardiovascular
complications, when adjusting for age and gender (hypertension odds ratio [OR] 2.16, confidence interval [CI] 2.10-2.22;
dyslipidemia OR 1.57, CI 1.54-1.60).
Conclusions: Individual-level data from EHRs may play an important role in chronic disease surveillance, namely through the
use of GIS. Promoting the quality and comprehensiveness of data, namely through patient involvement in their medical records,
is crucial to enhance the feasibility and usefulness of this approach.
(JMIR Public Health Surveill 2016;2(1):e12)  doi: 10.2196/publichealth.4319
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Introduction
Nowadays, data collected by health care providers in electronic
health records (EHRs) offer a unique opportunity to monitor
acute and chronic health conditions in real-time [1]. Moreover,
EHRs have the potential to become a cost-efficient, feasible,
and sustainable source of data for continuous population health
management [1]. One interesting way to analyze EHR-collected
data is with the use of geographic information systems (GIS).
GIS can track regional changes in disease incidence and
prevalence, analyze the environmental and social determinants
of health, identify health trends in local communities, and help
plan interventions for populations with the greatest need of
services [2].
GIS have the ability to give geographic context to EHR data
and seem useful when conducting community-level health needs
assessment. Indeed, geovisualization may be considered a
preliminary stage in focusing public health efforts in high-need
communities. Moreover, GIS are gathering increasing attention
in the identification and analysis of high-risk areas for
noncommunicable diseases, as is the case with “obesogenic
environments” [3,4] and diabetes [2,5-7].
The main objective of this study was to evaluate the feasibility
of using primary care individual-level EHR data and GIS, for
public health surveillance of type 2 diabetes in Portugal.
Methods
Setting
This study was based in Lisbon and in the neighboring region
of Tagus Valley, involving a total of 514 primary care centers.
All centers were computerized and had an EHR in use. At the
time of the study, there were three different types of EHR
software in use at the primary care system, but one of them
(named ‘SAM’, developed and funded by the Ministry of
Health) was used in the great majority of primary care practices
throughout the country. Data from primary care EHRs are
currently gathered in local health data warehouses, one of which
is in Lisbon.
In Portugal, health care is mostly publicly funded, and the
majority of patients has a unique patient identifier and access
to primary care services through the public primary care system.
Use of the International Classification of Primary Care (ICPC-2)
is common practice by primary care physicians in Portugal,
especially for registering diagnoses and health problems in the
EHR. Furthermore, current quality improvement indicators
defined by the Ministry of Health are mostly dependent on the
use of this classification.
Data Collection
Data collection was performed in September 2013 by the
Information Technology department of the Regional Health
Administration in Lisbon, from its data warehouse. The dataset
provided was de-identified (a pseudonymised identifier was
used for each patient). Individual-level data were collected on
adult patients (≥20 years of age) with the diagnosis of type 2
diabetes (identified by having the ICPC-2 code for type 2
diabetes - T90 - in the EHR field ‘problems list’). Duplicates
were removed from the dataset, as well as patients living outside
of the study area of Lisbon and Tagus Valley. Variables
collected were: age, gender, parish of residence, comorbidities,
and cardiovascular complications. Data on comorbidities and
cardiovascular complications were collected from the problems
list, by the presence or absence of the corresponding ICPC-2
codes (comorbidities: obesity, T82; hypertension, K86 and K87;
and dyslipidemia, T93; and complications: ischemic heart
disease, K74 and K76; myocardial infarction, K75; transient
cerebral ischemia, K89; stroke, K90; cerebrovascular disease,
K91; and peripheral vascular disease, K92).
The study was approved by the National Data Protection
Committee and by the Ethics Committee of the Regional Health
Administration in Lisbon.
Data Analysis
R Studio software (version 3.0.2) was used for the statistical
analyses. The ArcMap functionality of ArcGis (version 10;
ESRI) was used to create cloropleth maps. The prevalence of
diabetes by parish was mapped using a gray scale where the
darkest tone represented the highest prevalence. The same
method was applied to generate the comorbidities’ maps.
Results
Diabetes Prevalence
From a total of 3,659,868 individual records of people registered
in the primary care centers studied, 205,068 had the diagnosis
of type 2 diabetes, corresponding to a prevalence of 5.6%
(205,068/3,659,868). The mean age of these patients was 67.5
years (standard deviation 11.7) and 49.8% (102,155/205,068)
were female. The majority (190,912/205,068, 93.1%) of patients
were 50 years of age or older.
Hypertension was present in 71% (144,938/205,068) of the
patients with type 2 diabetes, obesity in 20% (41,473/205,068),
and dyslipidemia in 45% (92,000/205,068); 19%
(37,949/205,068) of the patients had none of these comorbidities.
No cardiovascular complications were registered for 85%
(173,227/205,068) of the patients. Ischemic heart disease was
the most prevalent cardiovascular complication, being present
in 7% of the patients (14,982/205,068), followed by stroke
(9,152/205,068, 5%), peripheral vascular disease
(7,683/205,068, 4%), and myocardial infarction (5,012/205,068,
2%). Transient cerebral ischemia and cerebrovascular disease
were registered in less than 2% of the patients with diabetes
(1,355/205,068 and 2,448/205,068, respectively).
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Figure 1. Mapping of diabetes prevalence and comorbiditiesâ€™ distribution, by parish, in Lisbon and Tagus Valley. Image copyright: the authors.
Geographic Analysis
The maps of prevalence for diabetes, dyslipidemia, hypertension,
and obesity showed considerable variation across the region of
Lisbon and Tagus Valley, with some parishes showing higher
proportions than others (Figure 1). Geographic analysis enabled
the identification of high-prevalence areas for diabetes,
hypertension, dyslipidemia, and obesity.
Discussion
Principal Findings
This study demonstrated the feasibility of collecting, analyzing,
and geographically displaying EHR data. Our study showed a
prevalence of diagnosed diabetes in primary care similar to
previously reported estimates, as well as a high proportion of
diagnosed hypertension, consistent with the literature [8]. One
way to apply this information would be to focus initial public
health efforts in areas where the prevalence of diabetes and
comorbidities seems to be higher, analyzing and addressing
possible reasons for that discrepancy, at the community-level.
Nevertheless, we found that individual-level data that is
extractable from the primary care information systems in
Portugal is still limited. We did not have access to data regarding
schooling, socio-economic status (SES), diabetes medication,
or biometric and lab data. Moreover, ethnicity data is not usually
allowed to be collected in Portugal, hampering a comprehensive
analysis of health care disparities in ethnic minority groups.
A more accurate and comprehensive GIS analysis was not
possible due to lack of access to individual-level zip code of
residence information or parish-level data on the social and
environmental determinants of health (eg, schooling, SES,
housing, walkability, green spaces, distance from grocery stores,
fast food chains).
Furthermore, for comprehensive outcomes monitoring to occur,
it should be possible to link data from primary care and hospital
EHRs, as well as other health institutions (eg, pharmacies, labs)
[9]. The integration of these sources of data, in combination
with information on the social and environmental determinants
of health, would have the potential to render a more complete
picture of the health state of communities [2].
Unfortunately, a great amount of data remains siloed in
institutions, fragmented, and generally inaccessible to the ones
who could bring meaning to it: clinicians, public health workers,
researchers, and, most importantly, patients. It is important that
health-related data are increasingly treated as a public good and
an essential element of a learning health care system.
Strengths and Limitations
This study had several strengths. It was the first in Portugal to
analyze data routinely collected from EHRs, producing
small-area maps of the distribution of diabetes and
comorbidities, in an entire region. The large sample size and
considerable amount of structured data ensure some robustness
to the results. The results of our study need to be interpreted in
the context of its cross-sectional design. Selection bias cannot
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be excluded, and two specific groups of individuals might be
missing from our sample: people with health care accessibility
issues, and people covered by private insurance, who do not
normally use the public primary care services.
Finally, it is important to keep in mind that the interpretation
of EHR data is generally subject to certain bias (eg, selection,
misclassification, surveillance), and should be done skeptically,
to distinguish real signals from random noise [10].
Implications for Clinical Practice, Research, and
Health Policy
Given the potential of this approach to improve chronic disease
surveillance, awareness should be promoted among policy
makers regarding the importance of data access, ownership,
security, privacy, quality, and comprehensiveness. Furthermore,
buy-in from clinicians should be promoted, and every effort
should be made for data entry not to be an extra burden in daily
practice. A necessary condition to improve data quality and
comprehensiveness is facilitating and streamlining its collection,
with clinician-friendly EHRs, and patient involvement in data
gathering and integration.
Future studies should explore the effects of small-area
characteristics (eg, socioeconomic and environmental factors,
health care services availability) on individual health, namely
in regions where the burden of diabetes is higher. Analyzing
the correlation of health outcomes with the social determinants
of health may facilitate the implementation of targeted
interventions and an optimal allocation of available resources.
Furthermore, by identifying high-risk localities, public health
efforts may be able to delineate and prioritize community-based
strategies, an important element of the Chronic Care model.
Conclusion
In summary, primary care EHR data shows potential to be used
in public health surveillance of chronic diseases, in particular
with the help of GIS. Clinical data routinely collected in daily
practice, when combined with information on the social and
environmental determinants of health, has the potential to render
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